Navigation Links
Coronary stent leads to complications

It is believed that the rate of clot formation inside a coronary stent is three times higher than the previous procedures. Now a days, the majority of angioplasties involve placement of a stent - a tiny metal device, inside the coronary artery to keep it open. But the very act of placing a stent in the artery irritates the vessel walls and may promote formation of a clot - ironically, the actual problem which the procedure is supposed to prevent.//

Till date, it has been thought that clot formation inside a stent was quite a rare event, affecting one per cent of patients. It is a serious complication, though, which often causes heart attack or sudden death. At the Dutch University Medical Center in the US, a new analysis was carried out by doctors which revealed that the clotting rate was three per cent more. Their investigation covered a larger group of patients who were, on the whole, at risk and required angioplasty.

People with diabetes or who had had a previous heart attack were more likely to suffer a clot in their stent. In order to cut the complication rate, the researchers say that may be people should be given anti-clotting therapy for longer around the time of angioplasty and probably use stent coated with an anti-clotting material in future.


'"/>




Page: 1

Related medicine news :

1. Transdermal HRT not cardioprotective in postmenopausal women with Coronary Artery Disease
2. Coronary heart disease bids Adieu
3. Older Men Surviving Coronary Bypasses
4. The Link Between Oxidized Phospholipids And Coronary Artery Disease
5. Cigarette Smoking Leads To Development Of Type 2 Diabetes In Patients With Coronary Artery Disease
6. New Cardiac Angiography Technique For Improved Imaging Of Coronary Veins
7. Effectiveness Of Drug-Releasing Coronary Stents
8. Children Are At The Risk Of Inheriting Coronary Disease
9. Statin Therapy in Patients with Acute Coronary Syndrome Improves Survival
10. Meditation may Improve Cardiac Risk Factors in Patients with Coronary Heart Disease
11. Microcirculation in Eye May Indicate Coronary Heart Death Risk
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/24/2017)... ... March 24, 2017 , ... In just two ... Frame vertical micro-veggies garden on Kickstarter . Surpassing the $100,000 milestone so ... nearly 2,000 consumers (and counting) already backing the campaign. , “We are ...
(Date:3/24/2017)... ... March 24, 2017 , ... ... the Advanced ERISA Benefit Claims Litigation seminar in Chicago, Illinois. She will ... The majority of cases litigated under ERISA involve claims for long-term disability benefits. ...
(Date:3/24/2017)... ... March 24, 2017 , ... ... ) announced their partnership to prep patients for colonoscopy at the HyGIeaCare® Center ... in 87th Ave., Miami, FL. , The HyGIeaCare® Prep, cleared by ...
(Date:3/24/2017)... ... 24, 2017 , ... “Finding Christ Through Social Media: Year ... chronicling the writer’s path toward true communion with God. “Finding Christ Through Social ... the creation of published author Lea Michelle Johnson, a follower of Christ, wife ...
(Date:3/24/2017)... ... March 24, 2017 , ... “The ... about real people of God in congregations across the United States. “The ... minister ordained in 1964 who has served congregations in seven states throughout his ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... , March 23, 2017 Ascendis Pharma ... innovative TransCon technology to address significant unmet medical needs ... host a conference call and webcast on Monday, April ... Endocrine Society in Orlando, Florida , ... pipeline candidates (TransCon Growth Hormone, TransCon PTH and TransCon ...
(Date:3/23/2017)... DIEGO , March 23, 2017  A ... fast and accurate identification of individuals who carry ... risk for a rare yet potentially deadly side ... and bipolar disorder.  The gene HLA-B*15:02 ... reactions such as Stevens-Johnson syndrome and toxic epidermal ...
(Date:3/23/2017)... Prima BioMed has presented encouraging ... IMP321 in combination with Keytruda, with one of the ... a complete response. Recruitment in the second cohort is ... fully recruited by Q317. Preliminary efficacy data from the ... are expected mid-year (recruitment in the 226-patient Phase IIb ...
Breaking Medicine Technology: